Masimo (NASDAQ: MASI) today announced the findings of a prospective study published in Pediatrics International in which Dr. Ya-Fei Liu and colleagues at Peking University First Hospital in Beijing ev
Terumo India, the Indian arm of Terumo Corporation (TSE: 4543), a global leader in medical technology, today announced the launch of FineGlide®, Sterile Pen Needle for patients requiring regular insul
AIIMS New Delhi and India Medtronic Private Limited, a wholly owned subsidiary of Medtronic plc, announced the opening of a state-of-the-art surgical robotics training center at AIIMS, New Delhi. The
ZEISS, an internationally leading technology company operating in the optics and optoelectronics industries showcased ‘ZEISS VISUFIT 1000’, a cutting-edge technological advancement in the optical indu
Stryker, one of the world’s leading medical technology companies, announced the launch of the SmartMedic platform at the 29th Annual Conference of the Indian Society of Critical Care Medicine in Indor
Avania, a leading, global medical technology contract research organization (CRO), today announced its appointment of Todd M. Pope as the new chairman of the board of directors. Todd brings 30 years o
Masimo (NASDAQ: MASI) today announced the limited market release of Sepsis Index (Si™), an early warning indicator designed to help clinicians identify possible sepsis in patients remotely monitored w
Phase III clinical trial of [18F]flurpiridaz PET diagnostic radiopharmaceutical meets co-primary endpoints for detecting Coronary Artery Disease (CAD) Trial also met its first key secondary endpoint,
/newsonfloor/media/post_banners/bEAdqLbMtZ1KgHuTSYbG.jpg)
/newsonfloor/media/post_banners/FGWWLY6SBmLhR1jGQ0Nq.jpg)
/newsonfloor/media/post_banners/2ZSHkaMOkBoZg9AcvBte.jpeg)
/newsonfloor/media/post_banners/xYmRuAv1UxtHXm0tSSIF.jpg)
/newsonfloor/media/post_banners/aodmT7ADa4adnt1L3neX.jpg)
/newsonfloor/media/post_banners/OeTOcHWcagmUcSSaOAdF.jpg)
/newsonfloor/media/post_banners/XsJKWZDlpAJSYdlV5YFs.jpg)
/newsonfloor/media/post_banners/kn5MQqcU7YiCSC8lfCDX.jpg)
![GE Healthcare and Lantheus Phase III Clinical Trial Finds [18F]flurpiridaz PET Radiotracer Could Improve Detection of Coronary Artery Disease](https://img-cdn.thepublive.com/fit-in/560x320/filters:format(webp)/newsonfloor/media/post_banners/OprjOgfJAobSFYs7l8S8.jpg)
/newsonfloor/media/post_banners/gsJXEW1EJe07AUDKVl97.jpg)
